Concepedia

Yulong Shi

YS

Statistics

Publications

18

Citations

1K

H-Index

14

Active since

2020

Affiliations

Shanghai Institute of Materia Medica(Current)

Chinese Academy of Sciences

University of Chinese Academy of Sciences

University of Science and Technology of China

Chinese Academy of Medical Sciences & Peking Union Medical College

Yulong Shi is an author at Shanghai Institute of Materia Medica specializing in drug discovery, pharmacology, and pharmacy.

Publications per year

2020–2025

18

Publications

18

Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation

Zhijian Xu, Yulong Shi, Zhengdan Zhu et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 332 citations · Full text

, , +17

Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19

Haiyu Xu, Shufen Li, Jiayuan Liu et al. · Proceedings of the National Academy of Sciences · 2023 · 129 citations · Full text

, , +17

ETCM v2.0: An update with comprehensive resource and rich annotations for traditional Chinese medicine

Yanqiong Zhang, Xin Li, Yulong Shi et al. · Acta Pharmaceutica Sinica B · 2023 · 121 citations · Full text

, , +17

D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19

Yulong Shi, Xinben Zhang, Kaijie Mu et al. · Acta Pharmaceutica Sinica B · 2020 · 87 citations · Full text

, , +17

Computational Insights into the Conformational Accessibility and Binding Strength of SARS-CoV-2 Spike Protein to Human Angiotensin-Converting Enzyme 2

Cheng Peng, Zhengdan Zhu, Yulong Shi et al. · The Journal of Physical Chemistry Letters · 2020 · 62 citations

, , +17

1–5 of 18